Constitutive androstane receptor (CAR) and liver X receptors (LXRs) were also reported as potential therapeutic targets for the treatment of obesity and atherosclerosis, respectively. The gene discussed is CXADR; the disease is obesity due to melanocortin 4 receptor deficiency.